CorVaPro

CorVaPro is indicated for:

Treatment of hypercholesterolaemia

• Adults, adolescents and children from 6 years of age with primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia)
• or mixed dyslipidaemia (type IIb) as a supplement to dietary measures in cases where the response to the diet alone and other non-pharmacological treatment (eg. physical activity, weight loss) is unsatisfactory.
• Adults, adolescents and children from 6 years of age with homozygous familial hypercholesterolaemia as a supplement to the diet and other hypolipidaemic treatments (eg. LDL apheresis), or alone if these are not recommended.

Prevention of cardiovascular accidents.

• Prevention of serious cardiovascular accidents for patients with high estimated risk of a first cardiovascular accident (see section 5.1), in addition to the correction of other risk factors.